Beovu AMD therapy now listed on the PBS

Almost 13,000 Australians could save thousands annually with the Pharmaceutical Benefits Scheme (PBS) listing of Beovu (brolucizumab) for neovascular age-related macular degeneration (nAMD) from this month, the Federal Government says. Read more

Ikervis ciclosporin eye drop now PBS-listed

Pharmaceutical firm Seqirus has announced that its new therapy Ikervis is now available via the Pharmaceutical Benefits Scheme (PBS), making it Australia’s first listed disease modifying ciclosporin eye drop for severe keratitis in adults with dry eye disease (DED).

Read more

SILMO to make APAC comeback

After coming and going from the Australian conference calendar, the SILMO global eyewear and lifestyle trade show is set to return to the Asia-Pacific region in 2023 with the launch of a Singapore event. Read more


Date changes for O=PEN HOUSE events

The O=PEN HOUSE multi-state equipment showcase convened by four of Australia’s leading ophthalmic equipment suppliers has pivoted to accommodate changing COVID-19 restrictions in NSW and Victoria. Read more